Skip to main content
Lawrence Recht, MD, Neurology, Palo Alto, CA

Lawrence David Recht MD

Neurooncology


Professor, Neurology & Neurological Sciences, Stanford University Medical Center

Join to View Full Profile
  • 875 Blake Wilbur DrRM Cc2221Palo Alto, CA 94304

  • Phone+1 650-725-8630

  • Fax+1 650-498-4686

Dr. Recht is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1982 - 1984
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1979 - 1982
  • University of Minnesota
    University of MinnesotaResidency, Internal Medicine, 1977 - 1979
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1977

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - 2027
  • MA State Medical License
    MA State Medical License 1984 - 2005
  • CT State Medical License
    CT State Medical License 1997 - 2001
  • MN State Medical License
    MN State Medical License 1978 - 1979
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Early Data Support Further Study of Ivosidenib in mIDH1 Glioma
    Early Data Support Further Study of Ivosidenib in mIDH1 GliomaJuly 17th, 2020
  • New Glioblastoma Trial Combines Plerixafor with Whole-Brain Irradiation
    New Glioblastoma Trial Combines Plerixafor with Whole-Brain IrradiationMay 28th, 2019

Grant Support

  • Cdon: A Novel Marker Of Neuronal Stem CellsNational Institute Of Neurological Disorders And Stroke2008
  • Clinical Trial: Peritumoral Brain Edema In Patients With Primary Malignant GliomNational Center For Research Resources2008
  • Clinical Trial: Hcrf For Patients With Malignant Brain Tumor WHO Require High-DoNational Center For Research Resources2008
  • Clinical Trial: Dexamethasone-Sparing Study Comparing (HERF) To PlaceboNational Center For Research Resources2008
  • Quantifying Cortical Neuron Production After TransplantationNational Institute Of Neurological Disorders And Stroke2007–2008
  • Spo 33555: Cdon: A Novel Marker Of Neural Stem CellsNational Institute Of Neurological Disorders And Stroke2007
  • Peritumoral Brain Edema In Patients With Primary Malignant Glioma;(Hcrf) To DEXNational Center For Research Resources2007
  • Hcrf For Patients With Malignant Brain Tumor WHO Require High-Dose DexamethasoneNational Center For Research Resources2007
  • Dexamethasone-Sparing Study Comparing Herf To PlaceboNational Center For Research Resources2007
  • Peritumoral Brain Edema In Patients With Malignant Brain TumorNational Center For Research Resources2006
  • Stem Cell Plasticity After Blastocyst ImplantationNational Institute Of Neurological Disorders And Stroke2003–2004
  • Stem Cell Plasticity After Blastocyst ImplantationNational Institute Of Neurological Disorders And Stroke2001–2002
  • Neural Stem Cells And Neuro-OncologyNational Cancer Institute2001–2002
  • Neural Stem Cells--Novel Antiglioma StrategiesNational Cancer Institute1998–2002
  • Treatment Of Glioblastomas With ImmunotoxinsNational Institute Of Neurological Disorders And Stroke1992–1996

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: